New York General Group has the world's most advanced science and technology, QTIS (Quantum Theory Informed Superintelligence).

This technology can be applied to a variety of industries, one of which is the pharmaceutical industry. In this case, New York General Group's algorithms have successfully allowed artificial intelligence to develop a new drug from scratch.

【Excerpt from the results of ordering QTIS to develop a new drug. QTIS has developed an entirely new chronic pain relief drug called "QuantumRelief."】

【Result of a similar instruction to a large language model (ChatGPT). Only general descriptions of atomic/molecular simulations and drug discovery were available.】

【QTIS-generated "QuantumRelief" package insert.】

The important point is that it took less than a minute from human instruction to the development of the drug by artificial intelligence. Our artificial intelligence also understands the spatial structure and temporal motion of atoms/molecules based on quantum mechanics, which enables highly accurate drug discovery.

The following is the original paper of the science and technology (QTIS).

Whole-Brain Emulation through the Lens of the Schrödinger Equation(To be submitted to NeurIPS 2024)

QTIS is also part of the "New York General Group Categorical Family" and is based on the following technology:

Technical Report: A Categorical Approach to Artificial Intelligence

We are currently seeking the following three types of partners:

・Joint research

・Business and capital alliances

・Media Coverage

Please feel free to contact us at the following e-mail address:

info@newyorkgeneralgroup.com